{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:25:09Z","timestamp":1789763109472,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["(NCT01448616)"],"award-info":[{"award-number":["(NCT01448616)"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.bbmt.2015.08.006","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T18:17:51Z","timestamp":1439057871000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus\u2013Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies"],"prefix":"10.1016","volume":"22","author":[{"given":"Christine","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.08.006_bib1","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.08.006_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas","volume":"105","author":"Krishnan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib3","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","article-title":"Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation","volume":"113","author":"Diez-Martin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2015.08.006_bib5","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/infdis\/jit086","article-title":"Long-Term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation","volume":"207","author":"Henrich","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.08.006_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.08.006_bib7","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2008-05-157511","article-title":"Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation","volume":"112","author":"Woolfrey","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","article-title":"Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years","volume":"163","author":"H\u00fctter","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2015.08.006_bib9","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I treat HIV-associated lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CCO.0b013e32835d814a","article-title":"Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradication","volume":"25","author":"Durand","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2015.08.006_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/aid.2014.0157","article-title":"Autograft HIV-DNA load predicts HIV-peripheral reservoir after stem cell transplatation for AIDS-related lymphoma patients","volume":"31","author":"Zanussi","year":"2015","journal-title":"AIDS Res Hum Retrovisurses"},{"key":"10.1016\/j.bbmt.2015.08.006_bib12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bbmt.2015.04.004","article-title":"Prospective validation of the predictive power of the Hematopoietic Cell Transplantation Comorbidity Index: a Center for International Blood and Marrow Transplant Research study","volume":"21","author":"Sorror","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.006_bib13","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/bmt.2011.230","article-title":"Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient","volume":"47","author":"Miceli","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.006_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-200544020-00001","article-title":"Interactions between antiretrovirals and antineoplastic drug therapy","volume":"44","author":"Antoniou","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bbmt.2015.08.006_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.293.7.817","article-title":"Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving haart","volume":"293","author":"Nettles","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2015.08.006_bib17","first-page":"2438","article-title":"More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32\/delta32 mutation","volume":"371","author":"H\u00fctter","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.08.006_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7326\/0003-4819-113-7-512","article-title":"Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection","volume":"113","author":"Lane","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2015.08.006_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198309153091114","article-title":"Bone marrow transplantation in AIDS","volume":"309","author":"Hassett","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.08.006_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(83)92855-6","article-title":"Lymphocyte transfusion in\u00a0case of acquired immunodeficiency syndrome","volume":"1","author":"Davis","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.08.006_bib21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood.V71.3.666.666","article-title":"Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation","volume":"71","author":"Verdonck","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00007890-198707000-00007","article-title":"Clinical and immunological restoration in patients with AIDS after marrow transplantation using lymphocyte transfusions from the marrow donor","volume":"44","author":"Vilmer","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.08.006_bib23","first-page":"1195","article-title":"Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin\u2019s lymphoma","volume":"18","author":"Gabarre","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.006_bib24","first-page":"49N","article-title":"Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation","volume":"88","author":"Bowden","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2015.08.006_bib25","first-page":"344","article-title":"Syngeneic bone-marrow transplantation and failure to eradicate HIV","volume":"5","author":"Aboulafia","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2015.08.006_bib26","first-page":"669","article-title":"Allogeneic bone marrow transplantation combined with multiple anti-HIVk-1 treatment in a case of AIDS","volume":"12","author":"Contu","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.006_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.bmt.1700930","article-title":"Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier","volume":"20","author":"Schneider","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.006_bib28","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related nonHodkin lymphoma: final analysis of 485 patient treated with resk-adapted intensive chemotherapy","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/088922200308972","article-title":"Decreased HIV-associated T cell apoptosis by HIV protease inhibitors","volume":"16","author":"Phenix","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.bbmt.2015.08.006_bib30","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.08.006_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2249.1998.00640.x","article-title":"Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis","volume":"113","author":"Johnson","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2015.08.006_bib32","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib33","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/QAD.0b013e3283635232","article-title":"Association of early HIV viremia with mortality after HIV-associated lymphoma","volume":"27","author":"Gopal","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.bbmt.2015.08.006_bib34","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V98.13.3857","article-title":"Autologous stem cell transplantation for HIV-associated lymphoma","volume":"98","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","article-title":"Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020","volume":"14","author":"Spitzer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.08.006_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V99.2.698","article-title":"Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome","volume":"99","author":"Kang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.08.006_bib37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2015.08.006_bib38","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/1469-0691.12589","article-title":"Efficacy and safety of antiretrovirals in HIV-infected patients with cancer","volume":"20","author":"Torres","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115005352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115005352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:57Z","timestamp":1761058437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115005352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1083879115005352"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.08.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus\u2013Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}